跳至主要内容
临床试验/NCT01868802
NCT01868802Unknown2 期

Ketamine for Treatment-resistant Depression: A Multicentric Clinical Trial in Mexican Population

Paul J. Lamothe1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2013年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
发起方
入组人数
60
试验地点
1
主要终点
Changes in baseline HDRS Score

研究概览

简要总结

A randomized multicentric parallel arms study involving the use of ketamine for treatment-resistant depression will be held at three national health provider clinics in the Mexican population. The purpose of this study is to determine whether clinical response seen in previous studies is replicable in this population.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age: 18-65 years old
  • Mayor Depressive Disorder Diagnosis based on DSM-IV TR.
  • Classification of MDD as treatment-resistant.
  • No brain structural abnormalities as evidenced by an MRI scan.
  • Signed acceptance of Informed Consent.

排除标准

  • Other psychiatric diagnosis apart from MDD.
  • Substance abuse or dependence (prior or during study).
  • Pregnancy.
  • Congestive heart disease.
  • Personal history of psychosis.
  • First-degree relative with history of psychosis.
  • Glaucoma.
  • Present neurological disease.
  • High blood or pulmonary artery pressure.
  • Declining the signing of the informed consent.

研究组 & 干预措施

Ketamine treated

Experimental

干预措施: Ketamine (Drug)

Control, placebo treated

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Changes in baseline HDRS Score

时间窗: 20 minutes before and 40 minutes after ketamine infusion.

The Hamilton Depression Rating Scale (HDRS) baseline score will be measured 20 minutes before ketamine infusion. After 40 minutes post-infusion, a second HDRS score will be obtained.

Daily change in HDRS post-ketamine infusion.

时间窗: 1,2,3,4,5,6 and 7. Days after ketamine infusion

On a daily basis, from day 1-7 post-ketamine infusion, changes in HDRS score will be measured during the daily psychiatric evaluation.

次要结局

  • Baseline blood pressure (BP).(20 minutes before ketamine infusion.)
  • Changes from baseline in blood pressure (BP)(every 5 minutes in a 300 minutes period)

研究者

发起方
Paul J. Lamothe
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Paul J. Lamothe

Chief of the Research Department, Neurological Center.

American British Cowdray Medical Center

研究点 (1)

Loading locations...

相似试验